PROFILING IMPURITIES AND DEGRADANTS OF BUTORPHANOL TARTRATE USING LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY AND LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY SUBSTRUCTURAL TECHNIQUES
Kj. Volk et al., PROFILING IMPURITIES AND DEGRADANTS OF BUTORPHANOL TARTRATE USING LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY AND LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY SUBSTRUCTURAL TECHNIQUES, Journal of pharmaceutical and biomedical analysis, 14(12), 1996, pp. 1663-1674
A rapid and systemic strategy based on liquid chromatography/mass spec
trometry (LC/MS) profiling and liquid chromatography/tandem mass spect
rometry (LC/MS/MS) substructural techniques was utilized to elucidate
the degradation products of butorphanol, the active ingredient in stad
ol(R) NS. This strategy integrates, in a single instrumental approach,
analytical HPLC, UV detection, full-scan electrospray mass spectromet
ry, and tandem mass spectrometry to rapidly and accurately elucidate s
tructues of impurities and degradants. In these studies, several low-l
evel degradation products were observed in long-term storage stability
samples of bulk butorphanol. The resulting analytical profile include
s information on five degradants including molecular structures, chrom
atographic behavior, molecular weight, UV data, and MS/MS substructura
l information. The degradation products formed during long-term storag
e of butorphanol tartrate included oxidative products proposed as 9-hy
droxy- and 9-keto-butorphanol, norbutorphanol, a ring-contraction degr
adant, and Delta 1, 10 alpha-butorphanol. These methodologies are appl
icable at any stage of the drug product cycle from discovery through t
o development. This library of butorphanol degradants provides a found
ation for future development work regarding product monitoring, as wel
l as a useful diagnositc tool for new degradation products.